From: Estimating the accumulative dose uncertainty for intracavitary and interstitial brachytherapy
 | Bladder | Rectum | ||||
---|---|---|---|---|---|---|
 | ICBT (n = 50) | ISBT (n = 47) | p | ICBT (n = 50) | ISBT (n = 47) | p |
DiffVol | 0.72–1.53 | 0.64–1.67 | 0.24 | 0.43–1.51 | 0.67–1.31 | 0.19 |
Dice | 0.97 (0.87–0.99) | 0.98 (0.81–1) | 0.17 | 0.95 (0.8–0.98) | 0.97 (0.87–1) | 0.01 |
 ≥ 0.9, n (%) | 48 (96) | 45 (95.7) |  | 45 (90) | 45 (95.7) |  |
Vol (cc) | 0.42 ± 0.40 | 0.28 ± 0.25 |  < 0.01 | 0.75 ± 0.46 | 0.31 ± 0.32 |  < 0.01 |
Vall (cc) | 4.43 ± 1.69 | 5.06 ± 2.44 |  < 0.01 | 4.26 ± 1.52 | 5.90 ± 2.15 |  < 0.01 |
D2cc (DIR/GEC) | 0.99 (0.94–1.05) | 0.96 (0.91–1.07) |  < 0.01 | 1.00 (0.96–1.08) | 0.94 (0.91–1.06) |  < 0.01 |
Overestimated, n (%) | 5 (10) | 6 (12.8) | Â | 6 (8) | 1 (10.6) | Â |